about
Interventions for chronic non-hypovolaemic hypotonic hyponatraemiaAcute kidney injury in critically ill cancer patients: an updateThe cell cycle biomarkers: promising research, but do not oversell themRecommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeMethodology used in studies reporting chronic kidney disease prevalence: a systematic literature reviewDiagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statementsRenal Biopsy in 2015--From Epidemiology to Evidence-Based IndicationsTowards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trialStatin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort studyFluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohortReducing the costs of chronic kidney disease while delivering quality health care: a call to action.Criteria for and Appropriateness of Renal Transplantation in Elderly Patients With End-Stage Renal Disease: A Literature Review and Position Statement on Behalf of the European Renal Association-European Dialysis and Transplant Association DescartesEpidemiology of acute kidney injury in children worldwide, including developing countries.What can we learn from registry data on peritoneal dialysis outcomes?Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis.Patients' perceptions of information and education for renal replacement therapy: an independent survey by the European Kidney Patients' Federation on information and support on renal replacement therapyComparison of the radioiodinated serum albumin (RISA) dilution technique with direct volumetric measurements in animal models of peritoneal dialysis.When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study.Clinical practice guideline on diagnosis and treatment of hyponatraemia.Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.Dietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review.The dialytic management of acute renal failure in the elderly.An update on the referral pattern of patients with end-stage renal disease.Vitamin D binding protein and the need for vitamin D in hemodialysis patients.The role of APD in the improvement of outcomes in an ESRD program.Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxinsDoes the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?Impact of peritoneal dialysis on patient and graft outcome after kidney transplantation.Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis[ERBP guideline on the management and evaluation of the kidney donor and recipient].Protein-bound solute removal during extended multipass versus standard hemodialysis.Pro/con debate: continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions.Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)†Disaster nephrology: a new concept for an old problemPrognostic robustness of serum creatinine based AKI definitions in patients with sepsis: a prospective cohort studyProtein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis.Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over StudyExternal Validation of a risk stratification model to assist shared decision making for patients starting renal replacement therapy.
P50
Q24200705-12AEB9A5-6F76-40DE-9B4D-F754D9E5F601Q26740168-00CDD65B-E617-4A71-9F55-68AF8A76D98BQ26747607-A2995B9A-C1D6-4BF8-AA3B-9747B50FF0E6Q26767011-EB343AE6-0964-4AD3-ADFE-1135B089919FQ26799639-12ADFAC2-FF47-4517-A697-8D38DC5D600BQ27016147-EC617A25-578F-4E39-B7D0-470B41918FE0Q28077046-5E554112-231B-49F7-8E12-84BCF1066D04Q28475759-41DBBBBB-14A6-42B6-A03D-961BB7C6E42EQ28732032-1C09C32D-14BD-4A6D-A770-6BAABFEB8CBAQ28742415-77A9EA61-A419-4B01-8172-2961FAEB3930Q30234324-3E2A1B9B-069B-4BED-B104-85C0C417D6E1Q30248730-63EF7CDE-FC9A-43B5-A3A6-E6AE3273070EQ30249591-7A976E4C-9A7E-42BA-BF4A-132E1A168D65Q33459757-1D33CC60-4377-4F64-84CB-DE07FCB53E0DQ33753534-DA001605-B911-44BC-973F-6147D3D151B1Q33982530-490E2030-0F9A-4C7A-B229-DB726A9CC333Q34149265-700416D7-DAF7-4473-8C3B-531222188EE1Q34183375-2EACFEAD-94CF-437A-8008-6E82ABBFFC7EQ34406779-E0663006-D657-4AF9-8983-74CB9079E7AFQ34497204-3D6CDB1D-CB80-4621-9231-B83738318FDEQ34572119-64A92C7A-D391-4715-BFFB-58B2709DBE91Q34600821-8FAFF257-3513-4C7B-9F66-C497648B75FCQ34619504-C95358A9-5A93-4F14-B1E8-1A4010A44C74Q34656993-A5526235-4F05-4E67-AC45-3B8764E41150Q35001084-9DA70DE0-D020-4BFB-AB35-7115F0B0C071Q35030559-C39F3551-39F3-4DA0-BD82-C549EE42B506Q35043483-6CDADDD3-90CF-4B1B-B98E-BA257558C835Q35151206-7FC4E8E9-B177-4406-8A38-10FA155C0EA7Q35156303-43ACEDFA-680F-4D7A-A99E-9DB5E5BD2368Q35328501-A95557E0-5F52-46DA-92AC-7107F1A3E5A3Q35503190-781D0F34-7FAA-40AE-8EA4-BDC3C475FE77Q35567092-9BB0E34C-1BA7-424D-9FC8-C0083CF34A18Q35573682-88472549-637A-4ABA-B403-6F49EA848101Q35574300-6A8CC053-F819-4B10-8FD1-3D2E1965724BQ35587014-B7689723-0CA0-4957-B436-631D82A14CF6Q35633455-56D08DC9-265E-491B-A3DE-ADE0A21BB400Q35704650-5C0AAA59-5834-44FC-A9DF-DD91115B8866Q35901218-D41709C0-74D2-44BA-8C43-985F12FAEA79Q35904420-B22FDA57-E190-4724-913A-0CFF3AFBD688Q35982994-DDF9D1E5-D52B-4536-BCE4-C2148BA06950
P50
name
Wim Van Biesen
@ast
Wim Van Biesen
@en
Wim Van Biesen
@es
Wim Van Biesen
@nl
type
label
Wim Van Biesen
@ast
Wim Van Biesen
@en
Wim Van Biesen
@es
Wim Van Biesen
@nl
prefLabel
Wim Van Biesen
@ast
Wim Van Biesen
@en
Wim Van Biesen
@es
Wim Van Biesen
@nl
P214
20146284377015331533
P31
P7859
viaf-20146284377015331533